
Alan G Wynne MD
Diabetes, Osteoporosis & Bone Metabolism Medicine, Pituitary Disorders & Neuroendocrinology, Thyroid
Endocrinologist at the Cotton-O'Neil Clinic in Topeka, KS
Join to view full profile
3520 SW 6th AveTopeka, KS 66606
Phone+1 785-368-9591
Dr. Wynne is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1991
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1985 - 1988
University of Missouri-Columbia School of MedicineClass of 1985
Certifications & Licensure
KS State Medical License 1991 - 2027
MN State Medical License 1986 - 1991
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification McKesson Radiology™, McKesson, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Publications & Presentations
PubMed
- 468 citationsTirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 tr...Stefano Del Prato, Steven E. Kahn, Imre Pavo, Govinda Weerakkody, Zhengyu Yang
Lancet. 2021-11-13 - 38 citationsEfficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metformin.Juan P. Frias, Alan G. Wynne, Beata Matyjaszek-Matuszek, Dagmar Bartaskova, David A. Cox
Diabetes, Obesity & Metabolism. 2019-09-01 - 175 citationsTHE GLUCAGONOMA SYNDROME : CLINICAL AND PATHOLOGIC FEATURES IN 21 PATIENTSRobert A. Wermers, Vahab Fatourechi, Alan G. Wynne, Larry K. Kvols, Ricardo V. Lloyd
Medicine. 1996-03-01
Press Mentions
Can Your Apple Watch Diagnose Thyroid Issues?April 16th, 2018
'It Saved My Life': How a Smartwatch Stopped a Woman's Health CrisisApril 12th, 2018
This Woman's Apple Watch Helped Detect Her Severe Thyroid ProblemApril 12th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: